121 related articles for article (PubMed ID: 11090379)
1. MR imaging of the breast in patients with positive margins after lumpectomy: influence of the time interval between lumpectomy and MR imaging.
Frei KA; Kinkel K; Bonel HM; Lu Y; Esserman LJ; Hylton NM
AJR Am J Roentgenol; 2000 Dec; 175(6):1577-84. PubMed ID: 11090379
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging of the breast in evaluating residual diseases at lumpectomy site soon after excisional biopsy.
Yang H; Liu H; Peng W; Hua Y
J Comput Assist Tomogr; 2012; 36(2):196-9. PubMed ID: 22446359
[TBL] [Abstract][Full Text] [Related]
3. Detection with MR imaging of residual tumor in the breast soon after surgery.
Soderstrom CE; Harms SE; Farrell RS; Pruneda JM; Flamig DP
AJR Am J Roentgenol; 1997 Feb; 168(2):485-8. PubMed ID: 9016232
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of residual disease using breast MRI after excisional biopsy for breast cancer.
Chae EY; Cha JH; Kim HH; Shin HJ; Kim H; Lee J; Cheung JY
AJR Am J Roentgenol; 2013 May; 200(5):1167-73. PubMed ID: 23617506
[TBL] [Abstract][Full Text] [Related]
5. Use of imprint cytology for assessment of surgical margins in lumpectomy specimens of breast cancer patients.
Bakhshandeh M; Tutuncuoglu SO; Fischer G; Masood S
Diagn Cytopathol; 2007 Oct; 35(10):656-9. PubMed ID: 17854083
[TBL] [Abstract][Full Text] [Related]
6. Postexcisional breast magnetic resonance imaging in patients with breast cancer: predictable findings of residual cancer.
Kim JA; Son EJ; Kim EK; Kim MJ; Kwak JY; Jeong J
J Comput Assist Tomogr; 2009; 33(6):940-5. PubMed ID: 19940664
[TBL] [Abstract][Full Text] [Related]
7. Intra-operative touch preparation cytology; does it have a role in re-excision lumpectomy?
Valdes EK; Boolbol SK; Cohen JM; Feldman SM
Ann Surg Oncol; 2007 Mar; 14(3):1045-50. PubMed ID: 17206481
[TBL] [Abstract][Full Text] [Related]
8. MRI before reexcision surgery in patients with breast cancer.
Lee JM; Orel SG; Czerniecki BJ; Solin LJ; Schnall MD
AJR Am J Roentgenol; 2004 Feb; 182(2):473-80. PubMed ID: 14736685
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of margin status in lumpectomy specimens and residual breast carcinoma.
Scopa CD; Aroukatos P; Tsamandas AC; Aletra C
Breast J; 2006; 12(2):150-3. PubMed ID: 16509840
[TBL] [Abstract][Full Text] [Related]
10. Breast MRI after conservation therapy: usual findings in routine follow-up examinations.
Li J; Dershaw DD; Lee CH; Joo S; Morris EA
AJR Am J Roentgenol; 2010 Sep; 195(3):799-807. PubMed ID: 20729463
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance mammography in the evaluation of recurrence at the prior lumpectomy site after conservative surgery and radiotherapy.
Preda L; Villa G; Rizzo S; Bazzi L; Origgi D; Cassano E; Bellomi M
Breast Cancer Res; 2006; 8(5):R53. PubMed ID: 16959028
[TBL] [Abstract][Full Text] [Related]
12. Treated ovarian cancer: MR imaging, laparotomy reassessment, and serum CA-125 values compared with clinical outcome at 1 year.
Low RN; Duggan B; Barone RM; Saleh F; Song SY
Radiology; 2005 Jun; 235(3):918-26. PubMed ID: 15914479
[TBL] [Abstract][Full Text] [Related]
13. Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability.
Kinkel K; Helbich TH; Esserman LJ; Barclay J; Schwerin EH; Sickles EA; Hylton NM
AJR Am J Roentgenol; 2000 Jul; 175(1):35-43. PubMed ID: 10882243
[TBL] [Abstract][Full Text] [Related]
14. Local recurrence of breast cancer after cytological evaluation of lumpectomy margins.
Cox CE; Pendas S; Ku NN; Reintgen DS; Greenberg HS; Nicosia SV
Am Surg; 1998 Jun; 64(6):533-7; discussion 537-8. PubMed ID: 9619174
[TBL] [Abstract][Full Text] [Related]
15. Lumpectomy specimen margins are not reliable in predicting residual disease in breast conserving surgery.
Tang R; Coopey SB; Specht MC; Lei L; Gadd MA; Hughes KS; Brachtel EF; Smith BL
Am J Surg; 2015 Jul; 210(1):93-8. PubMed ID: 25613784
[TBL] [Abstract][Full Text] [Related]
16. The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer.
Aziz D; Rawlinson E; Narod SA; Sun P; Lickley HL; McCready DR; Holloway CM
Breast J; 2006; 12(4):331-7. PubMed ID: 16848842
[TBL] [Abstract][Full Text] [Related]
17. Does magnetic resonance imaging accurately predict residual disease in breast cancer?
Stucky CC; McLaughlin SA; Dueck AC; Gray RJ; Giurescu ME; Carpenter SG; Grimsby GM; Apsey HA; Pockaj BA
Am J Surg; 2009 Oct; 198(4):547-52. PubMed ID: 19800466
[TBL] [Abstract][Full Text] [Related]
18. Utility of breast MRI for evaluation of residual disease following excisional biopsy.
Wilkinson J; Appleton CM; Margenthaler JA
J Surg Res; 2011 Oct; 170(2):233-9. PubMed ID: 21550064
[TBL] [Abstract][Full Text] [Related]
19. Association of clinical and pathologic variables with lumpectomy surgical margin status after preoperative diagnosis or excisional biopsy of invasive breast cancer.
Smitt MC; Horst K
Ann Surg Oncol; 2007 Mar; 14(3):1040-4. PubMed ID: 17203329
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study.
Schnall MD; Blume J; Bluemke DA; DeAngelis GA; DeBruhl N; Harms S; Heywang-Köbrunner SH; Hylton N; Kuhl CK; Pisano ED; Causer P; Schnitt SJ; Thickman D; Stelling CB; Weatherall PT; Lehman C; Gatsonis CA
Radiology; 2006 Jan; 238(1):42-53. PubMed ID: 16373758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
